Duncan Emerton at Pharma Intelligence on the biosimilars opportunity propelling Biocon's $3.3 bln Viatris deal

2051 Listen ins
 

Our guest today is Duncan Emerton, executive director, custom intelligence and analytics, at Informa Pharma Intelligence. Informa is a UK based business intelligence provider and consultancy. In this episode, Duncan explains some of the basics of why biosimilars are a huge opportunity and how Biocon's deal to purchase the biosimilars unit of its long-term partner Viatris ticks several boxes for the Bangalore company